No Prescription |
 |
 | ||
|
Evista Generic Raloxifene |
|
| ||
No Prescription » Prescription Drugs 7 » Evista Generic Raloxifene Product Origin: EU (Turkey) This product is able to be sourced and supplied at excellent prices because of favourable cross border currency conversions. All products are authentic brand names and will include a product information insert in English. Medical Information: Evista is used for: Treating and preventing osteoporosis (bone thinning) in women past menopause. Raloxifene affects the cycle of bone formation and breakdown in the body and reduces loss of bone tissue. Raloxifene is used to treat or prevent osteoporosis in postmenopausal women. Raloxifene is also used to reduce the risk of invasive breast cancer in postmenopausal women who have osteoporosis or who are otherwise at risk of invasive breast cancer. Evista is prescribed to treat and prevent osteoporosis the brittle-bone disease that strikes some women after menopause. A variety of factors promote osteoporosis. The more factors that apply to you the greater your chances of developing the disease. These factors include: Caucasian or Asian descentSlender buildEarly menopauseSmokingDrinkingA diet low in calciumAn inactive lifestyleOsteoporosis in the family Raloxifene (ral-OX-i-feen) is used to help prevent and treat thinning of the bones (osteoporosis) only in postmenopausal women. It works like an estrogen to stop the bone loss that can develop in women after menopause but it does not increase the bone density as much as daily 0.625 mg doses of conjugated estrogens. Raloxifene will not treat hot flashes of menopause and may cause hot flashes to occur. Also raloxifene does not stimulate the breast or uterus as estrogen does. Raloxifene lowers the blood concentrations of total and low-density lipoprotein (LDL) cholesterol the bad cholesterols but it does not increase concentrations of high-density lipoprotein (HDL) cholesterol the good cholesterol in your blood. Buy Evista Generic Raloxifene and other Prescription Drugs 7 products online at Medstore. 3666
About Evista Generic Raloxifene: Product Type: Prescription Drugs 7 Evista ( Generic Raloxifene ) Evista (Generic Raloxifene) Generic Raloxifene 60mg 28 Tablets Generic Raloxifene Evista
View more Prescription Drugs 7 No Prescription: NEW YORK, Oct. 5, 2011 /PRNewswire via COMTEX/ -- Reportlinker.com announces that a new market research report is available in its catalogue: European Pharmaceutical Market: Strategic Assessments of Leading Suppliers http://www.reportlinker.com/p0651431/European-Pharmaceutical-Market-Strategic-Assessments-of-Leading-Suppliers.html #utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication This report provides industry executives with strategically significant competitor information and analysis of the leading players in the European pharmaceutical market. The report provides a worldwide strategic overview of the pharmaceutical market, including: Sales forecast for major product segments: ethical, OTC, generics. Sales forecast for major drug categories: cardiovascular, gastrointestinal, antibiotic, CNS, respiratory, musculoskeletal, hormonal/genitourinary, dermatological, oncological, ophthalmic, and others. In addition, the report reviews major regulatory, technological, economic, demographic, and social trends with potentially significant impact on the market during the next five years, including discussion of such key issues as pricing, industry consolidation, market globalization, growing R&D cost, generics, as well as advances in genomics, proteomics, drug screening, tissue engineering, bioinformatics, and other technologies. The companies analyzed in this report include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis and Wyeth.
| ||
